secwatch.observer — SEC 8-K summary
======================================

Issuer:     Semnur Pharmaceuticals, Inc. (SMNR)
CIK:        0001913577
Form:       8-K
Filed at:   2023-08-30T23:59:59+00:00
Accession:  0001213900-23-072288
Event type: m_and_a
Sentiment:  positive
Materiality: 0.70
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Longevity Biomedical waives $30M minimum cash condition for Denali merger
-------------------------------------------------------------------------

- Longevity irrevocably waived the $30M minimum cash condition in the merger agreement with Denali Capital Acquisition Corp.
- Waiver effective August 29, 2023; removes a key closing condition for the business combination.
- Merger agreement originally signed Jan 25, 2023, amended April 11, 2023.
- Parties include Denali, Longevity, Holdco, Merger Subs, and seller representative Bradford A. Zakes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1913577/000121390023072288/0001213900-23-072288-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1913577/000121390023072288/ea184480-8k425_denalicap.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-072288

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer